Terms: = Breast cancer AND HOXD13, SPD, 3239, P35453, HOX4I
64 results:
1. spd-L1 and spd-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
2. Enzyme-catalyzed electrochemical aptasensor for ultrasensitive detection of soluble PD-L1 in breast cancer based on decorated covalent organic frameworks and carbon nanotubes.
Zhang Y; Chen S; Ma J; Zhou X; Sun X; Jing H; Lin M; Zhou C
Anal Chim Acta; 2023 Nov; 1282():341927. PubMed ID: 37923412
[TBL] [Abstract] [Full Text] [Related]
3. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic breast cancer (BC) Markers: CALR, NLRP3 Pathway and spd-L1 in PBMCs of HR+ and TNBC Patients.
Elgohary S; Eissa RA; El Tayebi HM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762557
[TBL] [Abstract] [Full Text] [Related]
4. Survivorship Navigation for Young Women With Early-Stage breast cancer.
Knelson LP; Rosenberg S; Snow C; Rigby K; Lynch J; Sella T; Morgans A; Partridge AH
Clin Breast Cancer; 2023 Oct; 23(7):746-751.e1. PubMed ID: 37625925
[TBL] [Abstract] [Full Text] [Related]
5. Hyperthermic intrathoracic extracorporeal chemotherapy for secondary malignant pleural disease.
Miller DL; Parks CS; Ange B; Bonta IR; Rich PT
J Surg Oncol; 2023 Sep; 128(4):604-611. PubMed ID: 37409778
[TBL] [Abstract] [Full Text] [Related]
6. Clinicoradiological course of abemaciclib-induced pneumonitis with histology findings.
Okayasu K; Kawasaki T; Kumagai J; Miyazaki Y
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130630
[TBL] [Abstract] [Full Text] [Related]
7. Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levels.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Okada M
Thorac Cancer; 2022 Nov; 13(22):3200-3207. PubMed ID: 36178187
[TBL] [Abstract] [Full Text] [Related]
8. The interaction between the soluble programmed death ligand-1 (spd-L1) and PD-1
Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F
Front Immunol; 2022; 13():830606. PubMed ID: 35935985
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.
Liu C; Ran R; Li X; Liu G; Xie X; Li J
Can Respir J; 2022; 2022():3982335. PubMed ID: 35721789
[TBL] [Abstract] [Full Text] [Related]
10. Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor.
Gershtein ES; Korotkova EA; Vorotnikov IK; Sokolov NY; Ermilova VD; Mochalova AS; Kushlinskii NE
Klin Lab Diagn; 2022 Feb; 67(2):76-80. PubMed ID: 35192751
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic prospect of soluble programmed cell death ligand-1 in cancer management.
Khairil Anwar NA; Mohd Nazri MN; Murtadha AH; Mohd Adzemi ER; Balakrishnan V; Mustaffa KMF; Tengku Din TADA; Yahya MM; Haron J; Mokshtar NF
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):961-978. PubMed ID: 34180502
[TBL] [Abstract] [Full Text] [Related]
12. End of life breast cancer care in women with severe mental illnesses.
Fond G; Pauly V; Duba A; Salas S; Viprey M; Baumstarck K; Orleans V; Llorca PM; Lancon C; Auquier P; Boyer L
Sci Rep; 2021 May; 11(1):10167. PubMed ID: 33986419
[TBL] [Abstract] [Full Text] [Related]
13. The clinical implication of soluble PD-L1 (spd-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte.
Han B; Dong L; Zhou J; Yang Y; Guo J; Xuan Q; Gao K; Xu Z; Lei W; Wang J; Zhang Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2893-2909. PubMed ID: 33688997
[TBL] [Abstract] [Full Text] [Related]
14. PD-L1 expression in tumor lesions and soluble PD-L1 serum levels in patients with breast cancer: TNBC versus TPBC.
Yazdanpanah P; Alavianmehr A; Ghaderi A; Monabati A; Montazer M; Tahmasbi K; Farjadian S
Breast Dis; 2021; 40(1):43-50. PubMed ID: 33523034
[TBL] [Abstract] [Full Text] [Related]
15. The Association Between Psychological Distress and cancer Mortality in the United States: Results from the 1997-2014 NHIS-NDI Record Linkage Study.
Lee H; Singh GK
Ann Behav Med; 2021 Jun; 55(7):621-640. PubMed ID: 33410477
[TBL] [Abstract] [Full Text] [Related]
16. Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions.
Incorvaia L; Fanale D; Badalamenti G; Porta C; Olive D; De Luca I; Brando C; Rizzo M; Messina C; Rediti M; Russo A; Bazan V; Iovanna JL
Oncoimmunology; 2020 Oct; 9(1):1832348. PubMed ID: 33178494
[TBL] [Abstract] [Full Text] [Related]
17. Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on breast cancer Cells.
Murugaiah V; Agostinis C; Varghese PM; Belmonte B; Vieni S; Alaql FA; Alrokayan SH; Khan HA; Kaur A; Roberts T; Madan T; Bulla R; Kishore U
Front Immunol; 2020; 11():1171. PubMed ID: 32733438
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies.
Wang L; Cohen JC; Devasenapathy N; Hong BY; Kheyson S; Lu D; Oparin Y; Kennedy SA; Romerosa B; Arora N; Kwon HY; Jackson K; Prasad M; Jayasekera D; Li A; Guarna G; Natalwalla S; Couban RJ; Reid S; Khan JS; McGillion M; Busse JW
Br J Anaesth; 2020 Sep; 125(3):346-357. PubMed ID: 32611524
[TBL] [Abstract] [Full Text] [Related]
19. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
[TBL] [Abstract] [Full Text] [Related]
20. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents.
Liu H; Ma J; Li Y; Yue K; Li L; Xi Z; Zhang X; Liu J; Feng K; Ma Q; Liu S; Guo S; Wang PG; Wang C; Xie S
J Med Chem; 2019 Dec; 62(24):11324-11334. PubMed ID: 31765154
[TBL] [Abstract] [Full Text] [Related]
[Next]
